Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease.

Kelly, Michael S; Lewis, Jelena; Huntsberry, Ashley M; Dea, Lauren; Portillo, Ivan

Kelly, Michael S; Lewis, Jelena; Huntsberry, Ashley M; Dea, Lauren; Portillo, Ivan.

Affiliation

Kelly MS; a Department of Pharmacy Practice , Chapman University School of Pharmacy , Irvine , CA , USA.
Lewis J; a Department of Pharmacy Practice , Chapman University School of Pharmacy , Irvine , CA , USA.
Huntsberry AM; b Department of Clinical Pharmacy , University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences , Aurora , CO , USA.
Dea L; c Pharmacy Practice Resident , Kindred Hospital , La Mirada , CA , USA.
Portillo I; d Chapman University , Orange , CA , USA.

Postgrad Med ; 131(1): 31-42, 2019 Jan.

Article in En | MEDLINE | ID: mdl-30449220

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Renal Insufficiency, Chronic/complications; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Albuminuria/etiology; Blood Glucose/drug effects; Diabetes Mellitus, Type 2/complications; Glomerular Filtration Rate/drug effects; Glycated Hemoglobin/drug effects; Humans; Kidney/drug effects; Kidney/physiopathology; Sodium-Glucose Transporter 2 Inhibitors/adverse effects; Treatment Outcome

Key words

SGLT2 inhibitors; albuminuria; chronic kidney disease; diabetes mellitus

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google